Medicines for Malaria Venture Clinical Trials
Sponsors / Medicines for Malaria Venture
Medicines for Malaria Venture appears as lead sponsor on 55 trial records in ClinicalTrials.gov. Of these, 1 are recruiting, 0 are active without new recruitment, and 47 have completed. The registry records 4 terminated or withdrawn trials for Medicines for Malaria Venture. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Planned participant enrollment across these trials sums to 19,376. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
55
Total Trials
1
Recruiting
0
Other Active
47
Completed
4
Terminated / Withdrawn
19,376
Total Enrollment
Termination reasons: Other50% · Recruitment25% · Efficacy25%
Recent Terminations
- Plasmodium Falciparum Infection"All treatment arms met the futility criteria for efficacy during the pre-planned interim analysis, therefore the study was stopped."
- Malaria, Falciparum"Inconsistent and unpredictable exposures were observed. Drug needed to be reformulated."
- Malaria"Decision taken to halt progression of mefloquine as a potential partner for OZ439 as a single dose cure due to low probability of success"
- Malaria"Due to slow recruitment the study was terminated prematurely by the Sponsor after 30 subjects had been included"
Active Trials (0 total)
- Malaria, Falciparum PHASE1NCT07011511